Our shared goal is to reduce the burden of cancer. While treatment has advanced, true victory lies in prevention. In the crucial arena of primary prevention for high-risk individuals and prevention of secondary cancers, our current clinical trial models are failing. We face a logistical and economic impasse that requires a strategic modernization of our…
Keep reading with a 7-day free trial
Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.